Report: Plan National Cancer 2020-2024 (Luxembourg)

forpolicymakers luxembourgcountry Go back to Luxembourg page

Primary purpose: To reduce the incidence and mortality of cancer through organized prevention, screening, and integrated care strategies.

Sponsor, manager or home institution: Ministre de la Santé.

Type of information: Outlines comprehensive strategies for cancer prevention, treatment, and research, including governance, resource allocation, and public health initiatives. It also details organized screening programs, patient support services, and digital health advancements to improve care and reduce cancer incidence and mortality. cancer incidence, risk of cancer, screening, number of deaths, year, sex, diagnosis, causes of death, cancer prevalence, tumour histology, tumour staging. Click here to learn more.

Data level: national level.

Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.

Access to information: Click here to access.

Mouth Throat Oropharynx Nasopharynx Hypopharynx Larynx Salivary glands Lips Tonsils base of tongue Voice box Esophagus Stomach Small intestine Large intestine Colon Rectum Anus Liver Gallbladder Bile ducts Pancreas Lung Trachea Bronchi Pleura Mediastinum Bone Cartilage Osteosarcoma Ewings sarcoma Skin Melanoma Scalp Lips Hands Feet Muscle Fat Tendon Ligament Blood vessels Connective tissue Sarcoma Angiosarcoma Liposarcoma Lobular Breast Nipple Areola Ductal Vulva Vagina Cervix Uterus Ovary Fallopian tubes Endometrium Prostate Testicles Penis Kidney Ureter Bladder Urethra Eye Brain Spinal cord Thyroid gland Parathyroid Adrenal glands Pituitary gland Pancreas Thymus gland Peritoneum Pericardium Retroperitoneum Mesothelium Blood Bone marrow Lymph nodes Spleen Leukemia dataOwner::Ministre de la Santé availableVariable::cancer incidence availableVariable::risk of cancer availableVariable::screening availableVariable::number of deaths availableVariable::year availableVariable::sex availableVariable::diagnosis availableVariable::causes of death availableVariable::cancer prevalence availableVariable::tumour histology availableVariable::tumour staging dataLevel::national level hasCancerType::C00-D48: All neoplasms isReport hasCancerType::C00-C97: All cancer types hasCancerType::C00-C14: Mouth/throat cancers hasCancerType::C15-C26: Digestive system cancers hasCancerType::C30-C39: Lung/chest cancers hasCancerType::C40-C41: Bone cancers hasCancerType::C43-C44: Skin cancers/melanoma hasCancerType::C45-C49: Soft tissue cancer hasCancerType::C50: Breast cancer hasCancerType::C51-C58: Female genitalia cancers hasCancerType::C60-C63: Male genitalia cancer hasCancerType::C64-C68: Urinary system cancers hasCancerType::C69-C72: Eye and brain cancer hasCancerType::C73-C75: Thyroid and other gland cancers hasCancerType::C76-C80: Cancers of unknown or unspecified areas hasCancerType::C81-C96: Cancers of the blood and immune system hasCancerType::C97-C97: Cancers in multiple locations from the start hasCancerType::D00-D09: Early-stage cancers not yet spread hasCancerType::D10-D36: Benign tumour hasCancerType::D37-D48: Growths of uncertain nature hasCancerType::unknown